Facebook
Twitter
LinkedIn
Forward
2024 Infectious Disease Board Review Course
McLean, VA US
The Infectious Disease Board Review (IDBR) Course is designed to help physicians prepare for the American Board of Internal Medicine (ABIM) Infectious Disease certification exam. This comprehensive review features exam-focused lectures presented by the Nation’s leading infectious disease experts, case-based reviews, online practice exams, and additional study guides and primers. Learners not taking the board exam will find the course provides a comprehensive and practical update on common topics and challenges in infectious diseases.
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Identify gaps in infectious diseases medical knowledge where further study is needed for board preparation and patient management
- Improve confidence for taking the initial certification exam or one of the maintenance of certification assessment options
- Identify strategies for integrating diagnostic results and patient symptoms to accurately diagnose infectious diseases
- Recommend appropriate treatment options for infectious disease patients
- Assess risk, determine prognosis, and apply principles from epidemiologic studies
- Identify best-practice guidelines to incorporate into the care of infectious disease patients
- Answer questions written in the specific format used by the ABIM for the certification and recertification examinations
The Ritz-Carlton, Tysons Corner
1700 Tysons Boulevard
McLean, VA
22102
United States
+1 (703) 506-4300
The Ritz-Carlton, Tysons Corner
The Ritz-Carlton, Tysons Corner is located in McLean, one of Northern Virginia's most desirable neighborhoods, our luxury hotel is connected to high-end shopping at Tysons Galleria and is a short distance from the iconic landmarks of downtown Washington, D.C.
Room Reservations
- Group Rate: $205.00 per night (state and local taxes not included)
- Cancellations are permitted 72 hours prior to arrival to avoid cancellation penalty of one night’s room and tax fee.
- Reservations can be booked directly through the room reservations link below or calling +1-703-744-3947 and refer to group name (Infectious Disease 2024 Board Review Meeting) or book your guestroom reservations by using the group discount booking link: https://book.passkey.com/e/
50747545 - The cutoff date for the block of rooms is Friday, July 26, 2024 or until rooms are sold out, whichever comes first. Reservations made after the cutoff date will be based on hotel availability and hotel's standard room rate.
Check-in | Check Out
- Check-in: 4:00 PM
- Checkout: 11:00 AM
Logistical Inquiries
If you have any additional questions about your hotel booking or other logistical arrangements, please email your inquiries to info@IDBoardReview.com.
COURSE DIRECTORS
John Bennett, MD*Bethesda, Maryland
Henry Masur, MD*Bethesda, Maryland
CO-DIRECTORS
Barbara D. Alexander, MD, MHS
Director, Transplant Infectious Diseases Service, Duke University Medical Center
Associate Professor of Medicine and Pathology, Duke University School of Medicine
Durham, North Carolina
Paul Auwaerter, MDClinical Director, Division of Infectious Diseases, Johns Hopkins Hospital
Professor of Medicine, Johns Hopkins University School of Medicine
Baltimore, Maryland
David Gilbert, MDDirector, Earle A. Chiles Research Center, Providence Portland Medical Center
Professor of Medicine, Oregon Health & Science University
Portland, Oregon
Roy Gulick, MD, MPHProfessor of Medicine, Weill Cornell Medical College
Chief, Division of Infectious Diseases, Weill Cornell Medical College
Gladys and Roland Harriman Professor of Medicine, Weill Cornell Medical College
New York, New York
Robin Patel, MDElizabeth P. and Robert Allen Professor of Individualized Medicine Vice Chair, Division of Clinical Microbiology
Director, Infectious Diseases Research Laboratory
Co-Director, Bacteriology Laboratory
Professor of Medicine and Microbiology, Mayo Clinic
Rochester, Minnesota
Andrew Pavia, MDChief, Division of Pediatric Infectious Diseases, University of Utah Health Sciences Center
George and Esther Gross Presidential Professor, University of Utah School of Medicine
Salt Lake City, Utah
Richard Whitley, MDCo-Director, Pediatric Infectious Diseases, Children’s Hospital of Alabama
Loeb Eminent Scholar Chair in Pediatrics, Distinguished Professor of Pediatrics,
Professor of Microbiology, Medicine, and Neurosurgery,
University of Alabama at Birmingham
Birmingham, Alabama
FACULTY
David M. Aronoff, MD, FIDSAProfessor of Medicine
Chair, Department of Medicine
Indiana University School of Medicine
Indianapolis, Indiana
Taison Bell, MDDirector, Medical ICU
Associate Chair, Department of Medicine
University of Virginia School of Medicine
Charlottesville, Virginia
Karen Bloch, MDAssociate Professor, Division of Infectious Diseases
Vanderbilt University Medical Center
Nashville, Tennessee
Helen Boucher, MDDean and Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts
Henry F. Chambers, MDProfessor of Medicine, University of California San Francisco
San Francisco, California
Shireesha Dhanireddy, MDProfessor, Department of Medicine, Division of Allergy and Infectious Diseases
University of Washington School of Medicine
Director, Harborview Infectious Diseases and Travel Clinic
Seattle, Washington
Susan Dorman, MDProfessor, Division of Infectious Diseases
College of Medicine, Medical University of South Carolina
Charleston, South Carolina
Rajesh Gandhi, MDDirector, HIV Clinical Services and Education, Massachusetts General Hospital
Director, Harvard Center for AIDS Research Clinical Core, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School
Boston, Massachusetts
Khalil G. Ghanem, MD, PhDDeputy Director of Education, Department of Medicine
Johns Hopkins Bayview Medical Center
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Steven M. Holland, MD *Bethesda, Maryland
Michael Klompas, MDHospital Epidemiologist
Brigham and Women's Hospital
Harvard Pilgrim Health Care Institute
Boston, Massachusetts
Camille Kotton, MDClinical Director, Transplant and Immunocompromised Host Infectious Diseases
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Frank Maldarelli, MD, PhD *Bethesda, Maryland
Edward Mitre, MDBethesda, Maryland
Sandra Nelson, MDAssistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Boston, Massachusetts
James Platts-Mills, MDAssociate Professor, Infectious Diseases
University of Virginia School of Medicine
Charlottesville, Virginia
Charlottesville, Virginia
Stacey Rubin Rose, MD, FACPAssociate Professor, Department of Medicine, Infectious Diseases SectionAssociate Director, Center for ProfessionalismBaylor College of MedicineHouston, Texas
Robin Patel, MDChair, Division of Clinical Microbiology
Consultant, Divisions of Clinical Microbiology and Infectious Diseases
Professor of Medicine and Microbiology, Mayo Clinic
Rochester, Minnesota
Michael S. Saag, MDProfessor of Medicine, Jim Straley Chair in AIDS Research
University of Alabama at Birmingham
Birmingham, Alabama
Jennifer L. Saullo, MD, PharmD
Transplant Infectious Diseases Service
Duke University School of Medicine
Transplant Infectious Diseases Service
Duke University School of Medicine
Durham, North Carolina
Pranita D. Tamma, MDDirector, Pediatric Antimicrobial Stewardship Program
Associate Professor of Pediatrics
Baltimore, Maryland
David L. Thomas, MD, MPHProfessor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Barbara W. Trautner, MD, PhDProfessor, Department of Medicine
Baylor College of Medicine
Houston, Texas
Allan R. Tunkel, MD, PhDProfessor of Medicine
The Warren Alpert Medical School of Brown University
Providence, Rhode Island
Kevin Winthrop, MD, MPHAssociate Professor of Infectious Diseases, Ophthalmology
Professor of Public Health and Preventive Medicine
Division of Infectious Diseases
Oregon University of Health Sciences
Portland, Oregon
Portland, Oregon
*Individual employees of the National Institutes of Health (NIH) have participated in the planning and development of the course, although the NIH is not an official sponsor. The views expressed by the participants do not necessarily represent the opinions of the NIH, DHHS, or the Federal Government.
**Subject to change
**Subject to change
Activity/Course Director(s)
John Bennett
has no relevant financial relationships to disclose at this time.
Planner(s)
henry masur
has no relevant financial relationships to disclose at this time.
Faculty(s)
Barbara Alexander, MD, MHS
has a financial relationship (Researcher) with Shire/Takeda;.
has a financial relationship (Consultant) with F2G;.
has a financial relationship (Consultant) with Scynexis;.
has a financial relationship (Advisor) with HealthTrackRx;.
has a financial relationship (Researcher) with Cidara;.
David Aronoff, MD, FIDSA, FAAM
has a financial relationship (Consultant) with Walmart;.
Paul Auwaerter
has no relevant financial relationships to disclose at this time.
Taison Bell, MD, MBA
has no relevant financial relationships to disclose at this time.
Karen Bloch, MD MPH
has no relevant financial relationships to disclose at this time.
Helen Boucher, MD
has a financial relationship (Consultant) with Elsevier;.
has a financial relationship (Consultant) with ASM;.
has a financial relationship (Consultant) with Sanford Guide;.
Shireesha Dhanireddy
has no relevant financial relationships to disclose at this time.
Susan Dorman
has no relevant financial relationships to disclose at this time.
Rajesh Gandhi, MD
has no relevant financial relationships to disclose at this time.
Khalil Ghanem, MD, PhD
has no relevant financial relationships to disclose at this time.
ROY GULICK, MD, MPH
has no relevant financial relationships to disclose at this time.
Steven Holland, MD
has no relevant financial relationships to disclose at this time.
Michael Klompas, MD, MPH
has a financial relationship (Royalties or Patent Beneficiary) with UpToDate;.
Camille Kotton, MD, FIDSA, FAST
has a financial relationship (Advisor) with Evrys;.
has a financial relationship (Consultant) with Abbott;.
has a financial relationship (Consultant) with Merck;.
has a financial relationship (Consultant) with Hookipa;.
has a financial relationship (Advisor) with Roche Diagnostics;.
has a financial relationship (Speaker) with Oxford Immunotec;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with Beigene;.
has a financial relationship (Consultant) with Vir;.
has a financial relationship (Advisor) with ResTORBio;.
has a financial relationship (Consultant) with Qiagen;.
has a financial relationship (Consultant) with Takeda;.
Frank Maldarelli
has no relevant financial relationships to disclose at this time.
Dorothy Martinez
has no relevant financial relationships to disclose at this time.
Edward Mitre
has no relevant financial relationships to disclose at this time.
Sandra Nelson, MD
has no relevant financial relationships to disclose at this time.
Robin Patel, MD
has a financial relationship (Consultant) with PhAST, Torus Biosystems, Day Zero Diagnostics, Mammoth Biosciences, and HealthTrackRx;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with CContraFect, TenNor Therapeutics Limited, APT and BIOFIRE;.
has a financial relationship (Consultant) with Pathogenomix;.
has a financial relationship (Royalties or Patent Beneficiary) with Dr. Patel has a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued;.
has a financial relationship (Consultant) with Netflix, Abbott Laboratories, Oxford Nanopore Technologies, and CARB-X;.
Andrew Pavia, M.D.
has a financial relationship (Consultant) with Haleon (spin off from GSK);.
has a financial relationship (Consultant) with Sanofi;.
James Platts-Mills, MD
has no relevant financial relationships to disclose at this time.
Stacey Rose, MD, FACP
has no relevant financial relationships to disclose at this time.
Michael Saag, MD
has no relevant financial relationships to disclose at this time.
Jennifer Saullo, MD, PharmD
has a financial relationship (Royalties or Patent Beneficiary) with UpToDate;.
has a financial relationship (Speaker) with Melinta Therapeutics;.
Pranita Tamma, MD, MHS
has no relevant financial relationships to disclose at this time.
David Thomas, MD
has a financial relationship (Advisor) with Excision Bio;.
has a financial relationship (Advisor) with Merck ;.
Barbara Trautner, MD, PhD
has a financial relationship (Research Funding (if you were the principal or named investigator)) with Peptilogics;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with Genentech;.
has a financial relationship (Consultant) with Genentech;.
Allan Tunkel
has no relevant financial relationships to disclose at this time.
Richard Whitley, M.D.
has a financial relationship (Advisor) with Treovir, LLC;.
has a financial relationship (Advisor) with Glaxo Smith Kline;.
has a financial relationship (Advisor) with Leyden Laboratories;.
has a financial relationship (Advisor) with Virios Therapeutics, LLC;.
has a financial relationship (Advisor) with Evrys Bio, LLC;.
Kevin Winthrop, MD, MPH
has a financial relationship (Research Funding (if you were the principal or named investigator)) with Insmed;.
has a financial relationship (Consultant) with AN2 Therapeutics;.
has a financial relationship (Consultant) with Insmed;.
has a financial relationship (Consultant) with Spero;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with Paratek;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with RedHill Biopharma;.
has a financial relationship (Consultant) with Paratek;.
has a financial relationship (Consultant) with RedHill Biopharma;.
has a financial relationship (Research Funding (if you were the principal or named investigator)) with AN2 Therapeutics;.
PHYSICIANS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The George Washington University School of Medicine and Health Sciences and the Infectious Disease Board Review, LLC. The George Washington University School of Medicine and Health Sciences is accredited by the ACCME to provide continuing medical education for physicians.
The George Washington University School of Medicine and Health Sciences designates this live internet activity for a maximum of 117 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 117 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
PHYSICIAN ASSISTANTS
PAs may claim a maximum of 117 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
NURSE PRACTITIONERS
For the purposes of recertification, AANPCB accepts AMA PRA Category 1 Credit™ issued by organizations accredited by ACCME as an equivalent number of hours of participation.
NON-PHYSICIAN CREDIT
Certificates of attendance will be provided to attendees who cannot accept AMA PRA Category 1 Credits.
-----------------
Registration Categories and Fees
Registration Category | Early Bird (Ends May 1, 2024) | Standard |
|---|---|---|
Physicians (Live) | $1,550 | $1,650 |
| Physicians (Virtual) | $1,450 | $1,550 |
Physicians-in-Training: Residents & Fellows (Live) | $1,450 | $1,550 |
| Physicians-in-Training: Residents & Fellows (Virtual) | $1,350 | $1,450 |
Allied Health Professionals: Non-Physicians (Live) | $1,450 | $1,550 |
| Allied Health Professionals: Non-Physicians (Virtual) | $1,350 | $1,450 |
Syllabus & USB Drive
Syllabus Option | Price |
|---|---|
Digital Syllabus | Free |
Printed Syllabus | $125.00 |
USB Drive | $50.00 |
| Print Syllabus + USB Drive | $175.00 |
Meeting Registration Includes
Access to the following course materials until December 31, 2025:
- Pre-course online materials – board prep question banks, primers and study guides, and online only lectures (available June 15, 2024)
- 5-day sessions – featuring faculty presentations, daily board review sessions, and faculty Q&A sessions.
- Access to recorded lectures until December 31, 2025 (available shortly after the close of the course)
- Digital syllabus in PDF format (printed syllabus and USB drive are available for an additional cost.
Accessing Course Materials
- Pre-course Online Materials - On June 15, you will receive an email from the course with instructions for accessing the pre-course online materials.
- Syllabus & USB Drive - If you purchase the print syllabus or USB drive with PDF files of the syllabus, you will receive them via mail the week of the live course.
Cancellation Policy
- Notification of cancellation must be received in writing via info@idboardreview.com. Registrations cannot be cancelled over the telephone.
- Cancellations received before June 15, 2024 are eligible for a refund of 100%, less a $50 processing fee.
- Cancellations received between June 15, 2024 and August 6, 2024 are eligible for a refund of 50%, less a $50 processing fee.
- Tuition is not refundable after August 6, 2024.
- Substitutions will be accepted only with written authorization from the original registrant.
- Note: An attendee who does not cancel in writing and does not complete the course is still responsible for payment.
Payment by Check
If you selected the check option for payment, please remit your check to:
IDBR, LLC
18348 Spark Drive
Suite 201 #102
Hagerstown, Maryland 21740
Unpaid Registration Policy
All unpaid registrations must be paid by either credit card or paper check within 30 days of the date of registration. If a registration fee is unpaid after 30 days from the date of registration, the registration will be canceled.